Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression.

Cavalleri T, Bianchi P, Basso G, Celesti G, Grizzi F, Bossi P, Greco L, Pitrone C, Valtorta E, Mauri G, Truini M, Dall'Olio FG, Brandi G, Sartore-Bianchi A, Ricciardiello L, Torri V, Rimassa L, Siena S, Mantovani A, Malesci A, Laghi L; Alleanza contro il Cancro (ACC) Colorectal Cancer Working Group.

Cancer Immunol Res. 2019 May;7(5):751-758. doi: 10.1158/2326-6066.CIR-18-0661. Epub 2019 Feb 25.

PMID:
30804005
2.

Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.

Porta C, Ippolito A, Consonni FM, Carraro L, Celesti G, Correale C, Grizzi F, Pasqualini F, Tartari S, Rinaldi M, Bianchi P, Balzac F, Vetrano S, Turco E, Hirsch E, Laghi L, Sica A.

Cancer Immunol Res. 2018 May;6(5):578-593. doi: 10.1158/2326-6066.CIR-17-0036. Epub 2018 Mar 27.

3.

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.

Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, Di Caro G, Cavalleri T, Rimassa L, Palmqvist R, Lugli A, Koelzer VH, Roncalli M, Mantovani A, Ogino S, Laghi L.

Oncoimmunology. 2017 Jul 12;6(12):e1342918. doi: 10.1080/2162402X.2017.1342918. eCollection 2017.

4.

Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy.

Malara A, Gruppi C, Celesti G, Abbonante V, Viarengo G, Laghi L, De Marco L, Muro AF, Balduini A.

Haematologica. 2018 Feb;103(2):e42-e45. doi: 10.3324/haematol.2017.173070. Epub 2017 Nov 16. No abstract available.

5.

Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Moshayoff V, Faktor O, Laghi L, Celesti G, Peretz T, Keret D, Cohen D, Israeli E.

PLoS One. 2016 Jul 21;11(7):e0159522. doi: 10.1371/journal.pone.0159522. eCollection 2016.

6.

Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.

Gagliano N, Celesti G, Tacchini L, Pluchino S, Sforza C, Rasile M, Valerio V, Laghi L, Conte V, Procacci P.

World J Gastroenterol. 2016 May 14;22(18):4466-83. doi: 10.3748/wjg.v22.i18.4466.

7.

Brief Report: Alternative Splicing of Extra Domain A (EIIIA) of Fibronectin Plays a Tissue-Specific Role in Hematopoietic Homeostasis.

Malara A, Gruppi C, Celesti G, Romano B, Laghi L, De Marco L, Muro AF, Balduini A.

Stem Cells. 2016 Aug;34(8):2263-8. doi: 10.1002/stem.2381. Epub 2016 May 4.

8.

Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis.

Abbonante V, Di Buduo CA, Gruppi C, Malara A, Gianelli U, Celesti G, Anselmo A, Laghi L, Vercellino M, Visai L, Iurlo A, Moratti R, Barosi G, Rosti V, Balduini A.

Stem Cells. 2016 Apr;34(4):1123-33. doi: 10.1002/stem.2285. Epub 2016 Jan 29.

9.

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.

Erreni M, Siddiqui I, Marelli G, Grizzi F, Bianchi P, Morone D, Marchesi F, Celesti G, Pesce S, Doni A, Rumio C, Roncalli MG, Laghi L, Mantovani A, Allavena P.

J Immunol. 2016 Jan 15;196(2):902-14. doi: 10.4049/jimmunol.1501335. Epub 2015 Dec 16.

10.

Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness.

Bonecchi R, Savino B, Caronni N, Celesti G, Mantovani A, Locati M.

Oncoimmunology. 2015 Jan 7;3(12):e955337. eCollection 2014 Dec.

11.

ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.

Savino B, Caronni N, Anselmo A, Pasqualini F, Borroni EM, Basso G, Celesti G, Laghi L, Tourlaki A, Boneschi V, Brambilla L, Nebuloni M, Vago G, Mantovani A, Locati M, Bonecchi R.

Cancer Immunol Res. 2014 Jul;2(7):679-89. doi: 10.1158/2326-6066.CIR-13-0202. Epub 2014 Apr 2.

12.

Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia.

Malesci A, Basso G, Bianchi P, Fini L, Grizzi F, Celesti G, Di Caro G, Delconte G, Dattola F, Repici A, Roncalli M, Montorsi M, Laghi L.

Br J Cancer. 2014 Mar 4;110(5):1228-35. doi: 10.1038/bjc.2013.827. Epub 2014 Jan 16.

13.

Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin.

Malara A, Currao M, Gruppi C, Celesti G, Viarengo G, Buracchi C, Laghi L, Kaplan DL, Balduini A.

Stem Cells. 2014 Apr;32(4):926-37. doi: 10.1002/stem.1626.

14.

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.

Celesti G, Di Caro G, Bianchi P, Grizzi F, Marchesi F, Basso G, Rahal D, Delconte G, Catalano M, Cappello P, Roncalli M, Zerbi A, Montorsi M, Novelli F, Mantovani A, Allavena P, Malesci A, Laghi L.

Br J Cancer. 2013 Oct 29;109(9):2424-33. doi: 10.1038/bjc.2013.565. Epub 2013 Oct 1.

15.

Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.

Celesti G, Di Caro G, Bianchi P, Grizzi F, Basso G, Marchesi F, Doni A, Marra G, Roncalli M, Mantovani A, Malesci A, Laghi L.

Gastroenterology. 2013 Sep;145(3):647-57.e15. doi: 10.1053/j.gastro.2013.05.011. Epub 2013 May 15.

PMID:
23684708
16.

Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?

Grizzi F, Celesti G, Basso G, Laghi L.

World J Gastroenterol. 2012 Dec 7;18(45):6532-6. doi: 10.3748/wjg.v18.i45.6532.

17.

Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.

Laghi L, Beghelli S, Spinelli A, Bianchi P, Basso G, Di Caro G, Brecht A, Celesti G, Turri G, Bersani S, Schumacher G, Röcken C, Gräntzdörffer I, Roncalli M, Zerbi A, Neuhaus P, Bassi C, Montorsi M, Scarpa A, Malesci A.

PLoS One. 2012;7(9):e46002. doi: 10.1371/journal.pone.0046002. Epub 2012 Sep 21.

18.

MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers.

Laghi L, Bianchi P, Delconte G, Celesti G, Di Caro G, Pedroni M, Chiaravalli AM, Jung B, Capella C, de Leon MP, Malesci A.

Clin Cancer Res. 2012 Jun 1;18(11):3142-53. doi: 10.1158/1078-0432.CCR-12-0175. Epub 2012 Apr 10.

19.

[Research on the therapeutic possibilities of nicotinic acid in massive doses in atherosclerosis].

COCUZZA F, PRIVITERA M, MISTRETTA A, CELESTI G.

Atti Soc Ital Cardiol. 1959;21(2):Comunicazioni 118-9. Italian. No abstract available.

PMID:
13855655

Supplemental Content

Loading ...
Support Center